SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-012642
Filing Date
2017-11-27
Accepted
2017-11-27 18:04:41
Documents
1
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111617rimon_wizepharma.html 3  
1 OWNERSHIP DOCUMENT f3111617rimon_wizepharma.xml 3 8755
  Complete submission text file 0001213900-17-012642.txt   10763
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047
Business Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047 972-3-7676999
Rimon Gold Assets Ltd (Reporting) CIK: 0001721808 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52545 | Film No.: 171223772

Mailing Address 32A HABARZEL ST. TEL AVIV L3 69710
Business Address
Raveh Abir (Reporting) CIK: 0001723699 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52545 | Film No.: 171223771